FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309721564> ?p ?o ?g. }

• W4309721564 endingPage "5751" @default.
• W4309721564 startingPage "5751" @default.
• W4309721564 abstract "Glioblastoma is the most common and lethal primary brain malignancy that almost inevitably recurs as therapy-refractory cancer. While the success of immune checkpoint blockade (ICB) revealed the immense potential of immune-targeted therapies in several types of cancers outside the central nervous system, it failed to show objective responses in glioblastoma patients as of now. The ability of glioblastoma cells to drive multiple modes of T cell dysfunction while exhibiting low-quality neoepitopes, low-mutational load, and poor antigen priming limits anti-tumor immunity and efficacy of antigen-unspecific immunotherapies such as ICB. An in-depth understanding of the GBM immune landscape is essential to delineate and reprogram such immunosuppressive circuits during disease progression. In this view, the present study aimed to characterize the peripheral and intratumoral immune compartments of 35 glioblastoma patients compared to age- and sex-matched healthy control probands, particularly focusing on exhaustion signatures on myeloid and T cell subsets. Compared to healthy control participants, different immune signatures were already found in the peripheral circulation, partially related to the steroid medication the patients received. Intratumoral CD4+ and CD8+ TEM cells (CD62Llow/CD45ROhigh) revealed a high expression of PD1, which was also increased on intratumoral, pro-tumorigenic macrophages/microglia. Histopathological analysis further identified high PSGL-1 expression levels of the latter, which has recently been linked to increased metastasis in melanoma and colon cancer via P-selectin-mediated platelet activation. Overall, the present study comprises immunophenotyping of a patient cohort to give implications for eligible immunotherapeutic targets in neurooncology in the future." @default.
• W4309721564 created "2022-11-29" @default.
• W4309721564 creator A5001329102 @default.
• W4309721564 creator A5008270426 @default.
• W4309721564 creator A5018970052 @default.
• W4309721564 creator A5022153571 @default.
• W4309721564 creator A5022533249 @default.
• W4309721564 creator A5023525515 @default.
• W4309721564 creator A5030189102 @default.
• W4309721564 creator A5033244957 @default.
• W4309721564 creator A5034062166 @default.
• W4309721564 creator A5041272001 @default.
• W4309721564 creator A5048171850 @default.
• W4309721564 creator A5053623492 @default.
• W4309721564 creator A5057539447 @default.
• W4309721564 creator A5077376956 @default.
• W4309721564 creator A5078433431 @default.
• W4309721564 creator A5080053959 @default.
• W4309721564 creator A5080353076 @default.
• W4309721564 creator A5088228708 @default.
• W4309721564 date "2022-11-23" @default.
• W4309721564 modified "2023-10-18" @default.
• W4309721564 title "Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients" @default.
• W4309721564 cites W1499993276 @default.
• W4309721564 cites W1588685142 @default.
• W4309721564 cites W1598604401 @default.
• W4309721564 cites W1918237073 @default.
• W4309721564 cites W1925967866 @default.
• W4309721564 cites W1980970302 @default.
• W4309721564 cites W1992883702 @default.
• W4309721564 cites W1999879982 @default.
• W4309721564 cites W2007747583 @default.
• W4309721564 cites W2011458181 @default.
• W4309721564 cites W2025770283 @default.
• W4309721564 cites W2038270678 @default.
• W4309721564 cites W2040773741 @default.
• W4309721564 cites W2041617023 @default.
• W4309721564 cites W2049784279 @default.
• W4309721564 cites W2066671159 @default.
• W4309721564 cites W2088422105 @default.
• W4309721564 cites W2097049582 @default.
• W4309721564 cites W2114701172 @default.
• W4309721564 cites W2117048610 @default.
• W4309721564 cites W2117728670 @default.
• W4309721564 cites W2127716652 @default.
• W4309721564 cites W2164986069 @default.
• W4309721564 cites W2167902402 @default.
• W4309721564 cites W2220215167 @default.
• W4309721564 cites W2253972308 @default.
• W4309721564 cites W2317575649 @default.
• W4309721564 cites W2406555542 @default.
• W4309721564 cites W2560367415 @default.
• W4309721564 cites W2595863515 @default.
• W4309721564 cites W2603523955 @default.
• W4309721564 cites W2677629498 @default.
• W4309721564 cites W2742412129 @default.
• W4309721564 cites W2790035192 @default.
• W4309721564 cites W2798160602 @default.
• W4309721564 cites W2878436114 @default.
• W4309721564 cites W2887361912 @default.
• W4309721564 cites W2894584497 @default.
• W4309721564 cites W2911871569 @default.
• W4309721564 cites W2997277554 @default.
• W4309721564 cites W2998102203 @default.
• W4309721564 cites W3014292375 @default.
• W4309721564 cites W3021411623 @default.
• W4309721564 cites W3026551532 @default.
• W4309721564 cites W3092411028 @default.
• W4309721564 cites W3138091752 @default.
• W4309721564 cites W3150063851 @default.
• W4309721564 cites W3181087071 @default.
• W4309721564 cites W4286491347 @default.
• W4309721564 doi "https://doi.org/10.3390/cancers14235751" @default.
• W4309721564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36497232" @default.
• W4309721564 hasPublicationYear "2022" @default.
• W4309721564 type Work @default.
• W4309721564 citedByCount "0" @default.
• W4309721564 crossrefType "journal-article" @default.
• W4309721564 hasAuthorship W4309721564A5001329102 @default.
• W4309721564 hasAuthorship W4309721564A5008270426 @default.
• W4309721564 hasAuthorship W4309721564A5018970052 @default.
• W4309721564 hasAuthorship W4309721564A5022153571 @default.
• W4309721564 hasAuthorship W4309721564A5022533249 @default.
• W4309721564 hasAuthorship W4309721564A5023525515 @default.
• W4309721564 hasAuthorship W4309721564A5030189102 @default.
• W4309721564 hasAuthorship W4309721564A5033244957 @default.
• W4309721564 hasAuthorship W4309721564A5034062166 @default.
• W4309721564 hasAuthorship W4309721564A5041272001 @default.
• W4309721564 hasAuthorship W4309721564A5048171850 @default.
• W4309721564 hasAuthorship W4309721564A5053623492 @default.
• W4309721564 hasAuthorship W4309721564A5057539447 @default.
• W4309721564 hasAuthorship W4309721564A5077376956 @default.
• W4309721564 hasAuthorship W4309721564A5078433431 @default.
• W4309721564 hasAuthorship W4309721564A5080053959 @default.
• W4309721564 hasAuthorship W4309721564A5080353076 @default.
• W4309721564 hasAuthorship W4309721564A5088228708 @default.
• W4309721564 hasBestOaLocation W43097215641 @default.
• W4309721564 hasConcept C121608353 @default.

• next